1.Canagliflozin plus metformin ER for the treatment of type 2 diabetes: the evidence to date

Tomlinson, B, Li, YH     More...

Tomlinson, B, Li, YH     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2023, Volume 24, Issue 18, Pages 1937-1947

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  3.2 

2.Evaluating gliclazide for the treatment of type 2 diabetes mellitus

Tomlinson, B, Li, YH     More...

Tomlinson, B, Li, YH, Chan, P     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2022, Volume 23, Issue 17, Pages 1869-1877

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2022影響因子:  3.2  发表年影響因子:  3.2 

3.An overview of alogliptin plus pioglitazone for the treatment of type 2 diabetes

Tomlinson, B, Chan,     More...

Tomlinson, B, Chan, P, Lam, CWK     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2021, Volume 23, Issue 1, Pages 29-42

收錄情况： WOS SCOPUS

WOS核心合集引用: 4  2022影響因子:  3.2  发表年影響因子:  4.103 

4.The role of sulfonylureas in the treatment of type 2 diabetes

Tomlinson, B, Patil,     More...

Tomlinson, B, Patil, NG, Fok, M, Chan, P, Lam, CWK     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2021, Volume 23, Issue 3, Pages 387-403

收錄情况： WOS SCOPUS

WOS核心合集引用: 13  2022影響因子:  3.2  发表年影響因子:  4.103 

5.Managing dyslipidemia in patients with Type 2 diabetes [Special Issue]

Tomlinson, B, Patil,     More...

Tomlinson, B, Patil, NG, Fok, M, Lam, CWK     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2021, Volume 22, Issue 16, Pages 2221-2234

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2022影響因子:  3.2  发表年影響因子:  4.103 

6.Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy

Tomlinson, Brian, La     More...

Tomlinson, Brian, Lam, Christopher Wai Kei, Chan, Paul, Zhang, Yuzhen     Less

Expert Opinion on Pharmacotherapy[1465-6566], Published 2020, Volume 21, Issue 17, Pages 2137-2151

收錄情况： WOS SCOPUS

WOS核心合集引用: 6  2022影響因子:  3.2  发表年影響因子:  3.889 

7.An evaluation of pitavastatin for the treatment of hypercholesterolemia

Chan, P, Shao, L, To     More...

Chan, P, Shao, L, Tomlinson, B, Zhang, YZ, Liu, ZM     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2019, Volume 20, Issue 1, Pages 103-113

收錄情况： WOS SCOPUS

WOS核心合集引用: 11  2022影響因子:  3.2  发表年影響因子:  2.878 

8.Evaluating the efficacy and safety of atorvastatin plus ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia

Ma, YB, Chan, P, Zha     More...

Ma, YB, Chan, P, Zhang, YZ, Tomlinson, B, Liu, ZM     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2019, Volume 20, Issue 8, Pages 917-928

收錄情况： WOS SCOPUS

WOS核心合集引用: 16  2022影響因子:  3.2  发表年影響因子:  2.878 

9.An evaluation of liraglutide including its efficacy and safety for the treatment of obesity

Lin, CH, Shao, L, Zh     More...

Lin, CH, Shao, L, Zhang, YM, Tu, YJ, Zhang, YZ, Tomlinson, B, Chan, P, Liu, ZM     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2019, Volume 21, Issue 3, Pages 275-285

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2022影響因子:  3.2  发表年影響因子:  2.878